2021
DOI: 10.3934/mbe.2021091
|View full text |Cite
|
Sign up to set email alerts
|

Artificial intelligence applied to neuroimaging data in Parkinsonian syndromes: Actuality and expectations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 70 publications
0
2
0
Order By: Relevance
“…To do this, they used a feature decomposition and kernel discriminant analysis (KDA) applying it to information from MR brain images from 830 subjects comprising 198 AD patients [51]. Other more recent studies have also carried out a methodological approach more similar to ours, having used strategies based on artificial intelligence for the detection of neurodegenerative diseases, although also based on clinical or neuroimaging information [52,53]. However, very few investigations use this methodology for the design of diagnostic algorithms based on information from molecular studies.…”
Section: Similarities and Differences With Previously Published Researchmentioning
confidence: 99%
“…To do this, they used a feature decomposition and kernel discriminant analysis (KDA) applying it to information from MR brain images from 830 subjects comprising 198 AD patients [51]. Other more recent studies have also carried out a methodological approach more similar to ours, having used strategies based on artificial intelligence for the detection of neurodegenerative diseases, although also based on clinical or neuroimaging information [52,53]. However, very few investigations use this methodology for the design of diagnostic algorithms based on information from molecular studies.…”
Section: Similarities and Differences With Previously Published Researchmentioning
confidence: 99%
“…According to previous research, there is a high probability that patients with PD develop cognitive impairment that may affect their quality of life; this impairment predominantly involves the cognitive domains of attention, executive function, and visuospatial skills [ 2 , 3 , 4 ]. Biomarkers obtained mainly from neuroimaging data were extensively discussed for finding predictors of cognitive dysfunction in Parkinson’s disease in a literature survey [ 5 , 6 ]. Indeed, it is crucial to identify the factors influencing cognitive decline that affect clinical prognosis and require early intervention [ 7 ].…”
Section: Introductionmentioning
confidence: 99%